Medtronic finalizes purchase of Scientia Vascular, merging access and therapeutic neurovascular portfolios

Medtronic announced the completion of its acquisition of Scientia Vascular. The deal combines Medtronic's access technologies with Scientia's therapeutic solutions. Both companies focus on neurovascular care. The integration will create a seamless product portfolio. It expands Medtronic's offerings for brain and spinal conditions. The move strengthens Medtronic's position in the neurovascular market. Integration teams will align product development and sales. The combined entity aims to improve patient outcomes and drive growth.